PiscoJMRio TintoHCampos PinheiroLet al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: Results of short- and mid-term follow-up. Eur Radiol2013; 23: 2561–2572.
2.
PiscoJMBilhimTPinheiroLCet al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: Results in 630 patients. J Vasc Interv Radiol2016; 27: 1115–1122.
3.
LittleMWBoardmanPMacdonaldACet al. Adenomatous-dominant benign prostatic hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: An age-matched case-control study. Cardiovasc Intervent Radiol2017; 40: 682–689.
4.
DjavanBZlottaAKratzikCet al. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL. Urology1999; 54: 517–522.
